Patents by Inventor YEHEZKEL BREMER

YEHEZKEL BREMER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Multiple-layer immune barrier for donor cells
    Patent number: 10064976
    Abstract: A system is provided, including a plurality of donor cells and a first alginate structure that encapsulates the plurality of donor cells. The first alginate structure has a guluronic acid concentration of between 64% and 74%. The system additionally includes a second alginate structure that surrounds the first alginate structure, the second alginate structure having a mannuronic acid concentration of between 52% and 60%. A selectively-permeable membrane is coupled at least in part to the second alginate structure. Other embodiments are also described.
    Type: Grant
    Filed: February 10, 2017
    Date of Patent: September 4, 2018
    Assignee: Beta-O2 Technologies Ltd.
    Inventors: Uriel Barkai, Avi Rotem, Yehezkel Bremer, Tova Neufeld
  • MULTIPLE-LAYER IMMUNE BARRIER FOR DONOR CELLS
    Publication number: 20170151369
    Abstract: A system is provided, including a plurality of donor cells and a first alginate structure that encapsulates the plurality of donor cells. The first alginate structure has a guluronic acid concentration of between 64% and 74%. The system additionally includes a second alginate structure that surrounds the first alginate structure, the second alginate structure having a mannuronic acid concentration of between 52% and 60%. A selectively-permeable membrane is coupled at least in part to the second alginate structure. Other embodiments are also described.
    Type: Application
    Filed: February 10, 2017
    Publication date: June 1, 2017
    Applicant: Beta-O2 Technologies Ltd.
    Inventors: Uriel Barkai, Avi Rotem, Yehezkel Bremer, Tova Neufeld
  • Multiple-layer immune barrier for donor cells
    Patent number: 9566366
    Abstract: A system is provided, including a plurality of donor cells and a first alginate structure that encapsulates the plurality of donor cells. The first alginate structure has a guluronic acid concentration of between 64% and 74%. The system additionally includes a second alginate structure that surrounds the first alginate structure, the second alginate structure having a mannuronic acid concentration of between 52% and 60%. A selectively-permeable membrane is coupled at least in part to the second alginate structure. Other embodiments are also described.
    Type: Grant
    Filed: August 10, 2016
    Date of Patent: February 14, 2017
    Assignee: Beta-O2 Technologies Ltd.
    Inventors: Uriel Barkai, Avi Rotem, Yehezkel Bremer, Tova Neufeld
  • MULTIPLE-LAYER IMMUNE BARRIER FOR DONOR CELLS
    Publication number: 20160346431
    Abstract: A system is provided, including a plurality of donor cells and a first alginate structure that encapsulates the plurality of donor cells. The first alginate structure has a guluronic acid concentration of between 64% and 74%. The system additionally includes a second alginate structure that surrounds the first alginate structure, the second alginate structure having a mannuronic acid concentration of between 52% and 60%. A selectively-permeable membrane is coupled at least in part to the second alginate structure. Other embodiments are also described.
    Type: Application
    Filed: August 10, 2016
    Publication date: December 1, 2016
    Applicant: Beta-O2 Technologies Ltd.
    Inventors: Uriel Barkai, Avi Rotem, Yehezkel Bremer, Tova Neufeld
  • Multiple-layer immune barrier for donor cells
    Patent number: 9446168
    Abstract: A system is provided, including a plurality of donor cells and a first alginate structure that encapsulates the plurality of donor cells. The first alginate structure has a guluronic acid concentration of between 64% and 74%. The system additionally includes a second alginate structure that surrounds the first alginate structure, the second alginate structure having a mannuronic acid concentration of between 52% and 60%. A selectively-permeable membrane is coupled at least in part to the second alginate structure. Other embodiments are also described.
    Type: Grant
    Filed: June 6, 2011
    Date of Patent: September 20, 2016
    Assignee: Beta-O2 Technologies Ltd.
    Inventors: Uriel Barkai, Avi Rotem, Yehezkel Bremer, Tova Neufeld
  • MULTIPLE-LAYER IMMUNE BARRIER FOR DONOR CELLS
    Publication number: 20110300191
    Abstract: A system is provided, including a plurality of donor cells and a first alginate structure that encapsulates the plurality of donor cells. The first alginate structure has a guluronic acid concentration of between 64% and 74%. The system additionally includes a second alginate structure that surrounds the first alginate structure, the second alginate structure having a mannuronic acid concentration of between 52% and 60%. A selectively-permeable membrane is coupled at least in part to the second alginate structure. Other embodiments are also described.
    Type: Application
    Filed: June 6, 2011
    Publication date: December 8, 2011
    Applicant: BETA-O2 TECHNOLOGIES LTD.
    Inventors: URIEL BARKAI, AVI ROTEM, YEHEZKEL BREMER, TOVA NEUFELD